一项名为《克洛伊·科尔法》的联邦法案旨在禁止以安全和同意关切为由对未成年人进行确认性别的治疗,同时对这种护理提出越来越多的政治和法律挑战。 A federal bill named the Chloe Cole Act aims to ban gender-affirming medical treatments for minors, citing safety and consent concerns, amid rising political and legal challenges to such care.

密苏里共和国Bob Onder提出的一项名为《克洛伊·科尔法》的联邦法案试图禁止对未成年人进行与性别有关的医疗,包括青春期阻塞剂、荷尔蒙和手术,并列举了对不可逆转的影响和知情同意的关切。 A federal bill named the Chloe Cole Act, introduced by Missouri Republican Rep. Bob Onder, seeks to ban gender-related medical treatments for minors, including puberty blockers, hormones, and surgeries, citing concerns over irreversible effects and informed consent. 该立法以反转性别倡导者克洛伊·科尔命名，赋予未成年人和家长在认为提供有害照护时的法律救济。 Named after detransition advocate Chloe Cole, the legislation grants minors and parents legal recourse if they believe harmful care was provided. 此举正值对青少年性别护理日益受到政治和法律审查之际，已有20位司法部长质疑美国医学会对此类治疗的支持，而纽约大学朗格尼分校等主要医疗机构因法律和财务风险暂停相关项目。 The move comes amid growing political and legal scrutiny of youth gender care, with 20 attorneys general questioning the American Medical Association’s support for such treatments, and major health institutions like NYU Langone suspending programs due to legal and financial risks. 同时,医疗保健和医疗援助服务中心的拟议规则将削减联邦对青年性别确认护理的供资,促使公共卫生领导人反对政策,认为政策得不到科学支持,危及病人福祉。 Meanwhile, the Centers for Medicare & Medicaid Services proposed rules would cut federal funding for gender-affirming care for youth, prompting opposition from public health leaders who argue the policies are unsupported by science and endanger patient well-being.